GENE ONLINE|News &
Opinion
Blog

Immuno-oncology
FDA Approves GSK’s PD-1 Medicine for Early-Detected Endometrial Cancer
2023-08-06
Coherus Acquiring Surface Oncology in $65M Stock Deal
2023-06-27
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare
2022-11-29
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
F-star Therapeutics Signs On to invoX Pharma for $161 Million to Stay Afloat
2022-06-24
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Exscientia Signs $1 Billion Worth AI Deal to Boost BMS’ Drug Discovery Pipeline
2021-05-21
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Embracing Artificial Intelligence and Machine Learning in Cancer Research and Care
2021-04-18
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
1 2
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top